Pharma Should Enlist Patients, Physicians To Fight Off-Label Litigation
Executive Summary
Drug makers should partner with patient advocacy groups and physicians to fight a growing pattern of litigation related to the dissemination of off-label drug information, Sidley Austin Brown & Wood Partner Paul Kalb said during a Drug Information Association workshop Feb. 22 in New York